60 Degrees Pharmaceuticals Inc
SXTP
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.1M
Close$
$-3.01
321% downside
Current Fair Value
321% downsideOvervalued by 321% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.10 Million |
|---|---|
| Enterprise Value | $-2,240,852.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.73 |
| Beta | 2.65 |
| Outstanding Shares | 1,725,758 |
Return
| Return on Equity | -159.44% |
|---|---|
| Return on Assets | -111.85% |
| Return on Invested Capital | -161.24% |
Valuation & Multiples
| P/E Ratio | -0.31 |
|---|---|
| PEG | -2.72 |
| Price to Sales | - |
| Price to Book Ratio | 0.45 |
| Enterprise Value to Revenue | -1.85 |
| Enterprise Value to EBIT | 0.28 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.76
Average shareholder expectationRevenue Estimate
$435,000
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.74
Average shareholder expectationRevenue Estimate
$185,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 11.26%▲ 9.61% |
|---|---|
| Total Invested | $340,074▲ 1408.29% |
| Investors Holding | 8▲ 1.00% |
ESG Score
No data